CVAC
CureVac NV
NASDAQ: CVAC · HEALTHCARE · BIOTECHNOLOGY
$4.66
+0.00% today
Updated 2026-04-30
Market cap
$1.05B
P/E ratio
6.96
P/S ratio
14.83x
EPS (TTM)
$0.67
Dividend yield
—
52W range
$3 – $6
Volume
1.1M
CureVac NV (CVAC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-74.11M | $-86.96M | $522.40M | $-733.13M | $-286.18M | $-267.89M | $101.85M |
| Capital expenditures | $14.72M | $12.22M | $47.35M | $127.90M | $93.22M | $55.20M | $18.44M |
| Depreciation | $3.78M | $7.16M | $10.67M | $15.67M | $23.74M | $23.39M | $18.81M |
| Stock-based comp | $-4.25M | $19.56M | $14.24M | $14.96M | $9.19M | $7.70M | $4.12M |
| Free cash flow | $-88.83M | $-99.19M | $475.05M | $-861.03M | $-379.40M | $-323.09M | $83.41M |
| Investing cash flow | $-4.26M | $28.18M | $-45.27M | $-127.90M | $-93.50M | $-55.20M | $-18.44M |
| Financing cash flow | $-112000.00 | $67.98M | $819.83M | $344.96M | $63.17M | $230.89M | $-5.11M |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |